USP General Chapter <1079> Pharmacopeia Forum. for Drug Products

Size: px
Start display at page:

Download "USP General Chapter <1079> Pharmacopeia Forum. for Drug Products"

Transcription

1 USP General Chapter <1079> Pharmacopeia Forum Good Storage and Transportation Practices for Drug Products IATA Vancouver/March 8-12, 2010 Mary Foster, PharmD USP Expert Committee Member, Packaging, Storage and Transportation Vice President, Quality Catalent Pharma Solutions, Inc. 30

2 Agenda Introduction to <1079> Themes Systems Approach Practices to Support Drug Product Integrity Accountability Throughout Chain of Custody Transparency Throughout Chain of Custody How To Use Guide 31

3 Introduction to Revised General Chapter <1079> Current Aimed at geographically localized li activities, iti i.e. within NA Discusses distribution chain in separate entities terms Revision in Pharmacopeia Forum Global application and accountability Discusses complexity within distribution chain and links to all entities 32

4 Introduction to Revised of General Chapter <1079> Drug Products (Human; Veterinary; Clinical Trial) Manufacturers, packagers; repackagers; wholesalers; distributors; hospital, mail-order and retail pharmacies Contractor s site; Laboratories Transportation vehicles (aircraft; automobiles; vans; containers; railcars; ships; trucks (large and small) Including Emergency Medical Services (EMS) vehicles and ambulances (removed from USP <1070>) Mail distributors (postal services; expedited mail services, e.g. DHL; FedEx) Excludes APIs & excipients, however 33

5 Themes <1079> Systems To provide a management systems approach Life-cycle management based on science, evidence & justification Improve efficiency in the supply chain Definitions to the systems in the context of storage & transportation Quality System Storage System Environmental System Transportation System Risk System 34

6 Themes <1079> Practices To provide a management systems approach To recommend standard practices including controls and SOPs All drugs - not just cold chain All operational space All entities ttes 35

7 Themes <1079> Accountability To provide a management systems approach To recommend standard practices To discuss accountability Ensure drug life-cycle Safety, identity, strength, quality, and purity Joint venture throughout supply chain 36

8 USP General Chapter <1079> Revision Themes Good Storage and Transportation Practices for Drug Products Systems Practices Accountability 37

9 USP General Chapter <1079> Revision Themes Good Storage and Transportation Practices for Drug Products Systems Practices Accountability 38

10 Systems Approach Systems Quality System (QMS) Storage System (SMS) Environmental System (EMS) Risk System (RMS) Transportation System (TMS) 39

11 Systems Approach Systems Quality System (QMS) Storage System (SMS) Environmental System (EMS) Transportation System (TMS) <1079> QMS Risk System (RMS) Set of policies, processes & procedures (SOPs) that enable the identification, measurement, control and improvement of the storage and transportation of drug product Defined roles and responsibilities Purposefully building documented alliances [e.g., Quality Agreements or Collaborative Agreements] 40

12 Systems Approach Systems Quality System (QMS) <1079> QMS = Set of policies, processes & procedures that enable the identification, measurement, control and improvement of the storage and transportation of drug product SOPs/Defined roles/collaborative Agreements Establish load configurations in cargo hold areas Sub-contracted or non-dedicated vehicles used in airport transportation to/from aircraft Document deviations and investigations to defined root cause(s) Transparent change control Self inspections; corporate audits; allow customer audits? 41

13 Systems Approach Systems Quality System (QMS) <1079> QMS = Set of policies, processes & procedures that enable the identification, measurement, control and improvement of the storage and transportation of drug product SOPs/Defined roles/collaborative Agreements Measuring key elements to ensure procedures are adequately followed from receipt to delivery Controlling critical parameters to ensure storage and transportation conditions have been appropriate while in their control Understand requirements of all relative drug regulatory agencies within own country; and, global regulatory agency 42

14 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> EMS A section of the QMS that covers environmental controls, including an adequate organization structure, roles & responsibilities, SOPs/policies/standards and processes for developing and maintaining an environmental program 43

15 Systems Approach Systems Environmental System (EMS) <1079> EMS = A section of the QMS that covers environmental controls, including an adequate organization structure, roles & responsibilities, SOPs/policies/standards and processes for developing and maintaining an environmental program. Environmental controls/roles/sops Over the life-cycle stability profile of products - airline time included Building stability profiles that cover potential excursions based on travel - airline cargo areas; tarmacs; airline hold areas Resolutions to CAPA s; preventive programs put in place (e.g., alert mechanism for temp breaches) Requiring SOPs, documentation and justifications Symbols and icons 44

16 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) <1079> SMS Risk System (RMS) Program to provide continuous improvement in the storage of drug products with key locations Buildings and facilities; vehicles and dispensing areas Basic processes Receiving/transferring; g storage/holding g 45

17 Systems Approach Systems Storage System (SMS) <1079> SMS = Program to provide continuous improvement in the storage of drug products with key locations in buildings and facilities, vehicles and dispensing areas. Storage program locations/processes Assures adequate controls (basics: extremes in temp, fire, water, explosion, pests) Prevent diversion 46

18 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> TMS Provide continuous improvement of drug product lifecycle by better and more efficient use of transportation processes 47

19 Systems Approach Systems Transportation System (SMS) <1079> TMS = Provide continuous improvement of drug product lifecycle by better and more efficient use of transportation processes Create transportation system that assures adequate product protection ti regardless of location Oversight program with accountability Notification to regulatory authorities Validation or qualification program for a vehicle should represent environmental extremes Temp map report define areas unsuitable; the minimum and maximum time allowances/tolerances 48

20 Systems Approach Systems Quality System (QMS) Environmental System (EMS) Storage System (SMS) Transportation System (TMS) Risk System (RMS) <1079> RMS A section of the QMS that covers the tools for determining how to handle deviations and excursions 49

21 Systems Approach Systems Risk System (SMS) RMS = <1079> A section of the QMS that covers the tools for determining how to handle deviations and excursions Process and SOPs when storage condition is not maintained Procedures when contamination ti is observed, e.g. pests, mold, moisture Security yprocedures Audit of transportation firms 50

22 1 2 3 Systems Practices Accountability 51

23 Standard Practices Practices Storage and Transportation Systems A B Warehouse Storage Hold Areas Vehicles Process Receiving Transferring Storing Holding Transporting Administering C Pharmacies Dispensers D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 52and control temperature and act on deviations.

24 Standard Practices Practices Storage and Transportation Systems A B Warehouse Storage Hold Areas Vehicles Process Receiving Transferring Storing Holding Transporting Administering C Pharmacies Dispensers D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 53and control temperature and act on deviations.

25 Standard Practices Practices Storage and Transportation Systems A Warehouse Storage Hold Areas B Vehicles - C Process Receiving Transferring Storing Holding Transporting e.g. Aircraft Pharmacies Dispensers Administering D End Users 1 Prevent preparation damage at times of uncontrolled storage. Limit it time out of storage conditions. Monitor and control temperature and act on deviations. 3 4 Determine if temperature mapping is required. Procedures and documentation required. 2 Determine temperature, air flow, and load patterns. Monitor 54and control temperature and act on deviations.

26 Standard Practices Practices Storage and Transportation Systems Process Environmental conditions (temperature, humidity, light) Receiving Storing Transporting Administering controlled and Transferring monitored Holding APreventive Warehouse Maintenance program in place Storage Environmental 4 Hold Areas monitoring i devices routinely calibrated at preset B Vehicles intervals with alert mechanism Communication within supply chain coordinated 2 to determine proper timing for receipt (and conversely be C Pharmacies transported) Dispensers - holidays, weekends or other forms of interruption D End Users Important consideration international shipments - customs stage supply chain 55

27 Systems Practices Accountability 56

28 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain 57

29 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Applicant holder or manufacturer for non-application preparations Transparency: removed time frames from current chapter (upon 2 hours of receipt ) It should follow for API s, excipients 58

30 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Delivery process RECALL - if it is found in any part of the supply chain to be adulterated due to storage/transportation activities, including counterfeiting 59

31 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity Administration and End User Entities Key to final safety, identity, strength, quality and purity 60

32 Accountability and Responsibility Accountability Accountability and responsibility must be maintained from: Manufacturing through Administration Manufacturing Delivery Administration Supply Chain - Responsible Entity All entities along the supply chain - ensure they handle appropriately for temperature t and other causes of preparation adulteration 61

33 Concluding Points General Intended to provide guidance on drug product lifecycle practices along the supply chain inclusive of all relative entities and the associated requirements that must be in place to protect preparations Joint venture mentality as an expression of the need for harmonization and transparency across all stakeholders for critical supply chain aspects such as environmental excursions for the benefit of the patient Equally important is to stay current and be ready to change as new solutions evolve 62

Mary G. Foster, PharmD, USP Chair Packaging, Storage & Distribution Expert Committee June 9, 2015, San Francisco

Mary G. Foster, PharmD, USP Chair Packaging, Storage & Distribution Expert Committee June 9, 2015, San Francisco AAPS Mini Symposium Frozen State Storage and Cold Chain Transportation Storage & Shipping of Biopharmaceuticals USP General Chapter Good Distribution Practices Latest Guidance Developments Mary

More information

ANSI Homeland Security Standards Panel Global Supply Chain Security Standards and Annual Plenary Meeting

ANSI Homeland Security Standards Panel Global Supply Chain Security Standards and Annual Plenary Meeting ANSI Homeland Security Standards Panel Global Supply Chain Security Standards and Annual Plenary Meeting Mary G. Foster, PharmD USP Chair, Expert Committee, Packaging, Storage & Distribution Aphena Pharma

More information

<1079> Good Storage and Distribution Practices

<1079> Good Storage and Distribution Practices Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico Good Distribution Practice Activities Suppliers Procuring, holding,

More information

Re: Proposed revisions to USP General Chapter <1079> Good Storage and Distribution Practices For Drug Products

Re: Proposed revisions to USP General Chapter <1079> Good Storage and Distribution Practices For Drug Products 30 September 2011 Scientific Liaison (PS05) Packaging and Storage Expert Committee US Pharmacopeia 12601 Twinbrook Pkwy Rockville MD 20852-1790 Re: Proposed revisions to USP General Chapter Good

More information

Feedback from Inspection Programme

Feedback from Inspection Programme Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure

More information

Summary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012

Summary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012 Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks

More information

Quality Risk Management: Excipients

Quality Risk Management: Excipients Quality Risk Management: Excipients ExcipientFest 2012 Presented by: Londa Ritchey, M.S. Director, Supplier Qualification Global Quality Operations Pfizer, Inc. Agenda Regulatory Environment Material Quality

More information

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority

Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders

More information

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification

More information

Good Distribution Practices Toolkit. Quality Management System 08 March 2016

Good Distribution Practices Toolkit. Quality Management System 08 March 2016 Good Distribution Practices Toolkit Quality Management System 08 March 2016 1 Quality Policy GDP, Legal, Environmental, H&S Processes & Systems Resources Risk Assessments 2 Quality Policy & Objectives

More information

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact Hours: 1.5 Objectives List some strategies regarding safe

More information

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain

QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse

More information

Good Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System

Good Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System Single Points of Contact Good Manufacturing Practices Surveillance and Monitoring Good Distribution Practices 10 1 9 Track and Trace System 2 8 3 7 Good Import/ Export Practices 4 6 5 Internet Sales Clinical

More information

Health Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012

Health Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012 Health Authority Inspection Management GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012 Abstract As global health authorities align in inspection standards and practices, key

More information

How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals?

How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals? How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals? An introduction to Pharmafreight 1 2 3 4 5 6 7 Established back in 2001 Part of Mach 2 Group

More information

Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals

Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals Pharma Process Forum BCN, October 28 th 205 Q3 205 2 The International Air Cargo

More information

Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang

Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang With much anticipation and efforts by those who work daily with perishable cargo,

More information

Counterfeit Drugs and Supply Chain Security

Counterfeit Drugs and Supply Chain Security Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children

More information

Logistic Provider Qualification: prerequisites and SLA

Logistic Provider Qualification: prerequisites and SLA Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational

More information

Technical Report No. 46 Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User

Technical Report No. 46 Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User Technical Report No. 46 Last Mile: Guidance for Good Distribution Practices for Pharmaceutical Products to the End User 2009 Last Mile: Guidance For Good Distribution Practices For Pharmaceutical Products

More information

Product serialization and traceability mandates. kpmg.com

Product serialization and traceability mandates. kpmg.com Product serialization and traceability mandates kpmg.com 1 Product serialization and traceability mandates Increasing threats to patient safety from counterfeited, adulterated, and diverted pharmaceutical

More information

<1079> GOOD STORAGE AND SHIPPING PRACTICES-General Chapters

<1079> GOOD STORAGE AND SHIPPING PRACTICES-General Chapters US. Pharmacopoeia USP29 GOOD STORAGE AND SHIPPING PRACTICES-General Chapters 1079 GOOD STORAGE AND SHIPPING PRACTICES This general information chapter is intended to provide general guidance concerning

More information

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products

Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER

More information

Inspection of API Manufacturers & Update on Registration Process

Inspection of API Manufacturers & Update on Registration Process Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers

More information

STUDY REQUEST FORM AND TRAQ DSS FORM

STUDY REQUEST FORM AND TRAQ DSS FORM Research Road Map April 2017 In This Issue Pharmacy Services for Research Study Request Form and TRAQ DSS FORM Management of Investigational Drugs Pharmacy Standard Operating Procedures IDS Team Qualifications

More information

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance

21CFR Ventilation, air filtration, air heating and cooling. 21CFR211 Details, Details. 21CFR Equipment Cleaning and Maintenance 21CFR211 Details, Details Kirsten L. Vadheim, Ph.D., RAC 7710 196th Avenue N.E. Redmond WA 98053 Tel: 651.260.6560 Fax: 425.868.4302 klvadheim@hotmail.com 21CFR211.46 Ventilation, air filtration, air heating

More information

IATA Chapter 17 Update on Changes. Donald Harrison, United Airlines Cargo

IATA Chapter 17 Update on Changes. Donald Harrison, United Airlines Cargo IATA Chapter 17 Update on Changes Donald Harrison, United Airlines Cargo Needs Identified Gap in the Cold Chain Airlines were identified as a broken link in the cold chain for transporting time and temperature

More information

The ABCs and Challenges of GMP The American Experience

The ABCs and Challenges of GMP The American Experience The ABCs and Challenges of GMP The American Experience The Canadian Association of Nuclear Medicine Toronto, Ontario April 22, 2017 Reiko Oyama, R.Ph., B.C.N.P. Washington University School of Medicine

More information

Supplier Assurance Program. CBE Pty Ltd

Supplier Assurance Program. CBE Pty Ltd Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.

More information

CGMP Requirements for Investigational Products

CGMP Requirements for Investigational Products PREP #6 CGMP Requirements for Investigational Products Ji-Eun Kim, RPh, PhD Research Pharmacist Regulatory Affairs Office of Research Compliance December 6, 2016 1 CME Disclosure Statement Northwell Health

More information

Agenda. What is considered as perishable? Food vs. Pharma: similarities and differences. Transportation & Infrastructure Requirements

Agenda. What is considered as perishable? Food vs. Pharma: similarities and differences. Transportation & Infrastructure Requirements Mr. Ingo Ocklenburg Mr. Michael Vorwerk Mr. Patrick Güth Agenda What is considered as perishable? Food vs. Pharma: similarities and differences Packaging and Handling Regulatory Requirements Transportation

More information

Drug Products, Labeling, and Packaging

Drug Products, Labeling, and Packaging 442 Pharmaceutical Industry: Drug Products, Labeling, and Packaging Positions Drug Products, Labeling, and Packaging Ready-to-Administer Packaging for Hazardous Drug Products Intended for Home Use (1711)

More information

Brussels Airport Gateway for the time and temperature controlled supply chain

Brussels Airport Gateway for the time and temperature controlled supply chain Brussels Airport Gateway for the time and temperature controlled supply chain Nathan De Valck Cargo Account manager Central location in Europe Brussels, a top European Logistics Hub, in the political,

More information

Overview sulla nuova guideline GDP

Overview sulla nuova guideline GDP AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation

More information

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17 SOP #: INV-100 Page: 1 of 5 1. POLICY STATEMENT: DF/HCC research pharmacies follow a standard set of policy requirements for clinical trials. 2. BACKGROUND: None 3. RESPONSIBLE PERSONNEL: 3.1. Research

More information

Timeline for the Drug Supply Chain and Security Act

Timeline for the Drug Supply Chain and Security Act April 2014 Timeline for the Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act, 2013) Overview The Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act,

More information

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00

Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00 Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel

More information

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS DRAFT VERSION GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS Published on the website of www.cdsco.nic.in on 10/01/2013 Notification The following draft guideline is hereby published

More information

The Quality Agreement evolved to fill these gaps and address these challenges.

The Quality Agreement evolved to fill these gaps and address these challenges. A Model for Pharmaceutical Supply Chain Quality Agreements Rafik H. Bishara, Steve Jacobs, and Dan Bell The Evolution of the Quality Agreement Over a decade ago, the way business was conducted between

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities

More information

Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment

Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment Aide-Memoire on Product Return: A Risk-based Rationale for Inspecting Returns and its Impacts on GDP Compliance Assessment Glaucia Karime Braga, Ph.D. USP Packaging and Distribution Expert Committee Member

More information

Quality in Global Sourcing

Quality in Global Sourcing Quality in Global Sourcing Steve Greer Global Compliance Leader P&G Beauty & Grooming Current Challenges 1 Supplier Related Incidents High profile material contamination incidents have highlighted risks

More information

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016 Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality

More information

Effective Risk Management A Catalyst For Quality Performance

Effective Risk Management A Catalyst For Quality Performance Page 1 of 6 Guest Column June 8, 2016 Effective Risk Management: A Catalyst For Quality Performance By Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates When we think of risk

More information

Developing a Robust Quality System to Assure Data Integrity

Developing a Robust Quality System to Assure Data Integrity Developing a Robust Quality System to Assure Data Integrity Maryann Gribbin Chief Compliance Officer, Faith & Royale Consultants Co-Chair PDA Data Integrity Task Force Data Integrity Facts or information

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

Assuring Food Safety. Presented by Jill Hollingsworth, DVM Vice President, Food Safety Programs

Assuring Food Safety. Presented by Jill Hollingsworth, DVM Vice President, Food Safety Programs Assuring Food Safety Presented by Jill Hollingsworth, DVM Vice President, Food Safety Programs Advancing American Competitiveness through Conformity Assessment: Legal Issues and Best Practices September

More information

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL

Quality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due

More information

Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil)

Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil) Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil) Kathrin Abelein Vice President Quality, R-Pharm, JSC First Russian GMP Conference 20. 22. September 2016 Agenda General information

More information

C3M Continuous Cold Chain Management. Active Monitoring Solutions for the Pharmaceutical Industry. Validating Asset Integrity

C3M Continuous Cold Chain Management. Active Monitoring Solutions for the Pharmaceutical Industry. Validating Asset Integrity C3M Continuous Cold Chain Management Active Monitoring Solutions for the Pharmaceutical Industry Key Benefits Comprehensive Information detailed data and dynamic mapping of temperature and humidity. Real

More information

Creating a Centralized Compounding Pharmacy within a Health System

Creating a Centralized Compounding Pharmacy within a Health System SALAS BLANCAS Amy Benner, PharmD Director of Central and Shared Services Scripps Health. Robert Miller, MS Quality Manager Scripps Health Ensuring the production of accurate and safe sterile compounded

More information

By Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution

By Christoph Frick and Nicola Spiggelkötter. Creating a Master Plan for Drug Warehousing, Transportation and Distribution By Christoph Frick and Nicola Spiggelkötter Creating a Master Plan for Drug Warehousing, Transportation and Distribution ISBN: 978-3-943267-93-8 Where a product trademark, registration mark, or other protected

More information

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016 New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology

Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer

More information

Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp

Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp 2016 Regulatory Compliance Associates Inc. Top Observation for 5 years Year Drugs #1 citation Device #1 citation

More information

Taking a Leap Toward Global Supply Chain Efficiency - Part II

Taking a Leap Toward Global Supply Chain Efficiency - Part II Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

POLICY Investigational Drug Service Transport

POLICY Investigational Drug Service Transport Investigational Drug Service Huntsman Cancer Hospital 1950 Circle of Hope, Suite 2110 Salt Lake City, Utah 84112 POLICY Investigational Drug Service Transport Purpose A. This policy establishes procedures

More information

San Jose, California, USA

San Jose, California, USA Glisland, Inc. San Jose, California, USA http://www.glisland.com Welcome to the Drug GMP World Current Good Manufacturing Practice cgmp ICH Q10 Pharmaceutical Quality System PQS GMP QSR Quality System

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Seite 1 von 10 Inspections, Compliance, Enforcement, and Criminal Investigations Laboratoire Atlas Inc. 6/25/09 hhsbluebird Department of Health and Human Services Public Health Service Food and Drug Administration

More information

SUPPLIER FOOD SAFETY ASSURANCE

SUPPLIER FOOD SAFETY ASSURANCE Chapter 12 SUPPLIER FOOD SAFETY ASSURANCE 1.0 PARTS OF A SUPPLIER FOOD SAFETY ASSURANCE PROGRAM 2.0 CHOOSING SUPPLIERS 2.1 Supplier Approval 2.2 Approved Supplier List 3.0 PRODUCT SPECIFICATIONS AND CONTROLS

More information

How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013

How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 Overview Introduction Who is DHL? What is GDP? DGF services Global approach DGF services Belgium 2 Introduction Elledin

More information

Pharma Market Growth and The Cost of Doing Business

Pharma Market Growth and The Cost of Doing Business Pharma Market Growth and The Cost of Doing Business May X, 2010 Agenda Pharma Market Overview Pharma Market Trends Cold Chain Complexities Freight Overview Pharma Costs and the Cost of Loss and Excursions

More information

Time & Temperature Logistics for Healthcare Products

Time & Temperature Logistics for Healthcare Products Time & Temperature Logistics for Healthcare Products Reality Check - A Non-Traditional Approach 2010 CNS Partnership Conference May 4, 2010 Christofer Matney Air Service Director Indianapolis International

More information

Global Integrated Solutions. Advanced Therapy Clinical Development and Commercialization

Global Integrated Solutions. Advanced Therapy Clinical Development and Commercialization Global Integrated Solutions Advanced Therapy Clinical Development and Commercialization There There is is a patient patient waiting. waiting. Fisher BioServices ensures that your advanced therapy product

More information

Building Effective National Strategies to Better Address Counterfeit Medicines

Building Effective National Strategies to Better Address Counterfeit Medicines Building Effective National Strategies to Better Address Counterfeit Medicines Expanding GMP, GDP, GPP, and Pharmacovigilance Systems ILISA B.G. BERNSTEIN, Pharm.D., J.D. Director of Pharmacy Affairs U.S.

More information

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those

More information

Mahendra Chemicals 7/13/15

Mahendra Chemicals 7/13/15 Mahendra Chemicals 7/13/15 Department of Health and Human Services Public Health Service Food and Drug Administration Silver Spring, MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED July 13, 2015 Mr. Rajnibhai

More information

Deficiencies found in Inspections and QP Responsibilities

Deficiencies found in Inspections and QP Responsibilities Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products

More information

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013. GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively

More information

Inspection-Ready IRT. Valarie Higgins President & Managing Director Almac Clinical Technologies.

Inspection-Ready IRT. Valarie Higgins President & Managing Director Almac Clinical Technologies. Inspection-Ready IRT Valarie Higgins President & Managing Director Almac Clinical Technologies www.almacgroup.com 2 Biologics License Application and the IRT Provider IRT 3 Agenda Why is IRT Becoming an

More information

Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation

Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Vision We aspire to be a partner of choice for global compliance & project management across the pharmaceutical value chain,

More information

A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY

A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY A PROCESS VALIDATION GUIDE FOR COLD CHAIN LOGISTICS: ENSURING COMPLIANCE GLOBALLY Presented by: Gary Hutchinson, President, Modality Solutions 8 th BSMA Conference Preparing the Biotech Supply Chain for

More information

S P O N S O R E D B Y

S P O N S O R E D B Y S P O N S O R E D B Y The Value of Visibility Data Seeing and Benefiting from Data after its Capture Example: Preparing for Serialization and Pedigree within the U.S. Pharmaceutical Supply Chain Agenda

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center

Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health

More information

Overview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products

Overview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products - HP97 04 Overview What this standard is about This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments

More information

Information Technology Trends and Best Practices The Industrial Internet of Things, Blockchain and Smart Contracts

Information Technology Trends and Best Practices The Industrial Internet of Things, Blockchain and Smart Contracts Information Technology Trends and Best Practices The Industrial Internet of Things, Blockchain and Smart Contracts Bob Celeste, Founder Center for Supply Chain Studies Neutral, Non-Profit, 501(c)(6) Exploration

More information

Temperature Monitoring (Clinical Trials)

Temperature Monitoring (Clinical Trials) York Foundation Trust R&D Unit Standard Operating Procedure Pharm/S48 Temperature Monitoring (Clinical Trials) IT IS THE RESPONSIBILITY OF ALL USERS OF THIS SOP TO ENSURE THAT THE CORRECT VERSION IS BEING

More information

Being Prepared for Track and Trace: DSCSA 101

Being Prepared for Track and Trace: DSCSA 101 Being Prepared for Track and Trace: DSCSA 101 Susanne Somerville, Founder The LinkLab Eric Garvin, Founder, The LinkLab Brian Daleiden, VP Industry Marketing and Co-Founder, TraceLink Objective of Today

More information

POST IMPORTATION TESTING

POST IMPORTATION TESTING POST IMPORTATION TESTING SAPRAA MEETING Karen Ford BYTES CONFERENCE CENTRE, MIDRAND 17 November 2017 Thomas Edison said : There is always a better way! 2 POST IMPORTATION TESTING EXEMPTION =PITE 3 OVERVIEW

More information

CSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical

CSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical CSafe Utilization in a Quality Management System Scott Garchar Manager - Global Business Development FedEx Custom Critical Agenda CSafe Relationship History Current State Review Quality Management System

More information

Increasing Focus on Excipients

Increasing Focus on Excipients The New Paradigm for Excipient Qualification and Supply Chain Control IPEC Update David R. Schoneker Director of Global Regulatory Affairs - Colorcon Chairman International Pharmaceutical Excipients Council

More information

Clinical Trial Unit, Hospital Pharmacy Central Denmark Region

Clinical Trial Unit, Hospital Pharmacy Central Denmark Region Clinical Trial Unit, Hospital Pharmacy Central Denmark Region Letter of Introduction The aim of this Letter of Introduction is to clarify general guidelines for working with the Hospital Pharmacy Central

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

Control of the Last Mile to ensure end-to-end compliance and protection of our products. Maurizio Caschera QA Manager

Control of the Last Mile to ensure end-to-end compliance and protection of our products. Maurizio Caschera QA Manager Control of the Last Mile to ensure end-to-end compliance and protection of our products Maurizio Caschera QA Manager Arena International Cannes 26-27 /02/2015 1 CO00993(1) Sanofi Pasteur MSD SNC au capital

More information

FSMA s New Sanitary Transportation Rule: How to Prepare Your Game Plan for Compliance

FSMA s New Sanitary Transportation Rule: How to Prepare Your Game Plan for Compliance FSMA s New Sanitary Transportation Rule: How to Prepare Your Game Plan for Compliance Speakers: Holly Mockus & Laura McMillan April 20, 2016 Today s Speakers Laura McMillan Vice President Training Development

More information

Test item OECD guideline No 19

Test item OECD guideline No 19 Test item OECD guideline No 19 Advisory Document of the Working Group on Good Laboratory Practice on the Management, Characterisation and Use of Test Items sophie.svensson@swedac.se Agenda Background Definitions

More information

Designing solutions for healthcare shippers

Designing solutions for healthcare shippers Bio Supply Management Alliance Conference Foster City, California (USA) October 8, 2013 Designing solutions for healthcare shippers Technical Fellow, Cold Chain Management Life Sciences & Specialty Services,

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

Chicago, The Gwen Hotel, 21 September HPCLC; Chicago, IL, USA; 21 September 2016

Chicago, The Gwen Hotel, 21 September HPCLC; Chicago, IL, USA; 21 September 2016 Chicago, The Gwen Hotel, 2 September 206 2 September 206 Background: The impact of mode shift on pharmaceutical logistics The pharmaceutical industry has relied heavily on the airline industry for its

More information

Inspection. Implementation of ICH Q8, Q9, Q10

Inspection. Implementation of ICH Q8, Q9, Q10 Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory

More information

ICH Quality Implementation Working Group POINTS TO CONSIDER

ICH Quality Implementation Working Group POINTS TO CONSIDER ICH Quality Implementation Working Group POINTS TO CONSIDER ICH-Endorsed Guide for ICH Q8/Q9/Q10 Implementation Document date: 16 June 2011 International Conference on Harmonisation of Technical Requirements

More information

Advancing GDP Compliance Standards In Airline Transportation: Raising the QA Bar for Biopharma. Chris Fore Compliance Manager

Advancing GDP Compliance Standards In Airline Transportation: Raising the QA Bar for Biopharma. Chris Fore Compliance Manager Advancing GDP Compliance Standards In Airline Transportation: Raising the QA Bar for Biopharma Chris Fore Compliance Manager 9th BSMA Conference Foster City, CA 10/20/2016 Introduction There has been an

More information